Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment
- Wall St ends up with Goldman; Dow posts biggest weekly rise since June
- Goldman Sachs (GS) Smashes Analyst 3Q Views on Robust M&A and Underwriting Activity
- Tesla (TSLA) Stock: Jefferies Raises Price Target on Higher Capacity Ramp and Sustained Demand, Berlin Giga Will Set New Design and Assembly Standards Says Analyst
- Food, fuels lift U.S. import prices in September
- SEC to Allow First Ever Bitcoin (BTC) ETF - Report
Former GSK Executive Stephen Pyke will lead and direct the operational execution and development of all facets of Parexel’s clinical data and digital strategy to better leverage data insights in support of Patients-First focus
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, today announced the appointment of Stephen Pyke as the company’s Executive Vice President, Clinical Data and Digital Services. In this newly created role, Pyke will lead and direct the operational execution and development of all facets of Parexel’s patient data strategy to differentiate the company as an industry leader in patient data insights.
“Steve brings more than 25 years of broad pharma industry experience to this pivotal new role,” said Sy Pretorius, MD, President, Clinical Development and Chief Medical Officer at Parexel. “A biostatistician by training, his expertise will help us further align our strategy and focus on the patient. By bringing together our data capabilities across the organization under one umbrella, we will be able to drive greater efficiencies and insights and move innovations forward more quickly to benefit patients.”
Prior to joining Parexel, Pyke was Senior Vice President & Development Head, Digital Data & Analytics at GlaxoSmithKline where he led efforts to rapidly deliver a tech-enabled modernization and innovation program utilizing Agile ways of working, enabling better use of clinical data as well as productivity and efficiency gains to yield a step change in clinical trial cycle acceleration.
The new Clinical Data and Digital Services group combines Parexel’s existing Scientific Data Organization, Global Data Operations, Real-World Evidence and Scientific Data Technology functions. “By reimagining our data support infrastructure, Parexel is leading the way in developing and implementing a winning strategy to learn from every patient and every datapoint to bring the company’s patient data vision to life,” added Dr. Pretorius.
The pandemic placed into sharper focus the need to learn from every patient, irrespective of whether data is collected in a traditional, controlled clinical trial or in the real-world setting. The announcement of a strengthened clinical data and digital services strategy further demonstrates Parexel’s Patients-First focus and aligns well with current market opportunity to continue to innovate and evolve patient data solutions to help develop and deliver new therapies.
About ParexelParexel supports the development of innovative new medicines to improve the health of patients. We provide services to help life sciences and biopharmaceutical clients everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services to leveraging real world insights, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do. Parexel was named “Best Contract Research Organization” in December 2020 by an independent panel for Informa Pharma Intelligence. For more information, visit parexel.com and follow us on LinkedIn, Twitter, and Instagram.
Christine RogersVice President, Corporate Communications+1 984 900 6485Christine.email@example.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e507e7e2-5353-4418-a504-8898e28123ed
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Award of Petroleum Exploration Rights in Nareli Block
- Daymond John's Black Entrepreneurs Day Awards $250,000 in NAACP Grants to Black Businesses Across the US
- HNST, SAM, SAVA, WDH SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!